Mainstream

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

Post ContentosurRead More

You might also be interested in reading Solv Protocol targets over $1T in idle Bitcoin with institutional yield vault.

August 6, 2025
In Mainstream